文献速递肿瘤 PET/CT放射性药物与辐射防护

使用18F-FDG PET无创评估异基因造血干细胞移植后胃肠道急性移植物抗宿主病

Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using 18F-FDG PET.
PubMed 文献 · J Nucl Med · 2022-04-21

该前瞻性研究纳入51例临床疑似胃肠道急性GVHD的异基因造血干细胞移植患者,在7天内行18F-FDG PET/CT及上下消化道内镜活检对照。23例(45.1%)活检确诊,结肠GVHD段SUVmax高于正常结肠段(4.1 vs 2.3,P=0.006),上消化道无差异。定量分析敏感性69%、特异性57%,定性分析分别为70%、76%。结论认为18F-FDG PET是有用的无创诊断试验,但无法区分GVHD与非GVHD炎症改变。

要点

  • 23/51例(45.1%)活检确诊胃肠道急性GVHD,结肠受累22/22例(100%),上消化道19/23例(82.6%)。
  • 结肠GVHD阳性段SUVmax 4.1(95%CI 3.6-4.5)高于正常结肠段2.3(1.9-2.7),P=0.006。
  • 定量PET敏感性69%、特异性57%、阴性预测值73%、阳性预测值59%;定性分析分别为70%、76%、76%、68%。

核心结论

  • 18F-FDG PET是胃肠道急性GVHD有用的无创诊断试验,GVHD存在时总是累及结肠且通常为全结肠受累,提示疑似急性GVHD时经乙状结肠镜获取结肠活检足以进行组织学确认。
  • 18F-FDG PET不能区分结肠急性GVHD与非GVHD炎症改变。

研究设计与样本

  • 前瞻性研究,51例临床疑似胃肠道急性GVHD的异基因造血干细胞移植患者行18F-FDG PET/CT,随后7天内行上下消化道内镜。
  • 对4个上消化道和4个结肠段的内镜活检组织学与相应节段定量18F-FDG PET/CT SUVmax进行比较,并行ROC分析及单独的定性视觉分析。

主要发现

  • 51例中23例(45.1%)活检确诊急性胃肠道GVHD,其中上消化道受累19/23例(82.6%),结肠受累22/22例(100%)。
  • 23例中1例未行结肠镜检查;22例结肠受累者中21例为整个结肠连续性受累。
  • 结肠GVHD阳性段SUVmax为4.1(95%CI 3.6-4.5),高于正常结肠段的2.3(1.9-2.7),P=0.006。
  • 上消化道节段未见差异。
  • 定量18F-FDG PET/CT检测GVHD的敏感性69%、特异性57%、阴性预测值73%、阳性预测值59%;定性分析分别为70%、76%、76%、68%。

关键数值与推荐

  • 结肠GVHD阳性段SUVmax 4.1(95%CI 3.6-4.5)vs 正常结肠段2.3(1.9-2.7),P=0.006。
  • 定量PET:敏感性69%、特异性57%、阴性预测值73%、阳性预测值59%。
  • 定性分析:敏感性70%、特异性76%、阴性预测值76%、阳性预测值68%。

临床怎么用

  • 作者认为18F-FDG PET是胃肠道急性GVHD有用的无创诊断试验。
  • 作者认为疑似急性胃肠道GVHD时经乙状结肠镜获取结肠活检足以进行组织学确认。
  • 作者指出18F-FDG PET不能区分结肠急性GVHD与非GVHD炎症改变。

局限性

  • 18F-FDG PET不能区分结肠急性GVHD与非GVHD炎症改变。
  • 23例中1例未行结肠镜检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute graft-versus-host disease of the gastrointestinal tract (acute GIT-GVHD) often complicates allogeneic hemopoietic stem cell transplantation (AHSCT). 18F-FDG PET/CT is known to detect active inflammation and may be a useful noninvasive test for acute GIT-GVHD. The objective of this study was to evaluate the diagnostic utility of 18F-FDG PET/CT to noninvasively assess patients with clinically suspected acute GIT-GVHD. Fifty-one AHSCT patients with clinically suspected acute GIT-GVHD prospectively underwent 18F-FDG PET/CT scanning followed by upper and lower GIT endoscopy within 7 d. Endoscopic biopsies of 4 upper GIT and 4 colonic segments were obtained for histology to compare with corresponding quantitative segmental 18F-FDG PET/CT SUVmax Receiver-operating-characteristic curve (ROC) analysis was performed to determine predictive capacity of 18F-FDG PET/CT SUVmax for acute GIT-GVHD. A separate qualitative visual 18F-FDG PET/CT analysis was also performed for comparison. Results: Twenty-three of 51 (45.1%) patients had biopsy-confirmed acute GIT-GVHD, with 19 of 23 (82.6%) having upper GIT and 22 of 22 (100%) colonic involvement. One of 23 patients did not undergo a colonoscopy. GVHD involved the entire colon contiguously in 21 of 22 patients. For quantitative analysis, histology from 4 upper GIT and 4 colonic segments were compared with 18F-FDG PET/CT SUVmax Colonic segments positive for GVHD had a higher SUVmax (4.1 [95% CI, 3.6-4.5]) than did normal colonic segments (2.3 [1.9-2.7], P = 0.006). No difference was demonstrated in upper GIT segments. Quantitative 18F-FDG PET/CT yielded a 69% sensitivity, 57% specificity, 73% negative predictive value, and 59% positive predictive value for the detection of GVHD compared with 70%, 76%, 76%, and 68%, respectively, for qualitative analysis. Conclusion: 18F-FDG PET is a useful noninvasive diagnostic test for acute GIT-GVHD, which when present always involves the colon and usually in its entirety, suggesting colonic biopsy obtained by sigmoidoscopy is adequate for histologic confirmation when acute GIT-GVHD is suspected. Of note, 18F-FDG PET cannot distinguish acute GIT-GVHD from non-GVHD inflammatory changes in the colon.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cherk MH, Khor R, Barber TW, et al. Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using 18F-FDG PET. J Nucl Med. 2022. PMID: 35450959. doi:10.2967/jnumed.121.263688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。